14-day Premium Trial Subscription Try For FreeTry Free
$18.31
+0.150 (+0.83%)
At Close: May 01, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $15.26 $19.04 Wednesday, 1st May 2024 AVDL stock ended at $18.31. This is 0.83% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 4.44% from a day low at $18.23 to a day high of $19.04.
90 days $11.82 $19.04
52 weeks $9.50 $19.04

Historical Avadel Pharmaceuticals plc prices

Date Open High Low Close Volume
Feb 20, 2024 $13.57 $13.57 $12.58 $12.86 1 431 904
Feb 16, 2024 $14.08 $14.11 $13.51 $13.57 640 105
Feb 15, 2024 $14.35 $14.36 $14.15 $14.20 644 145
Feb 14, 2024 $14.18 $14.50 $14.04 $14.25 259 766
Feb 13, 2024 $14.25 $14.51 $13.96 $14.15 563 352
Feb 12, 2024 $14.50 $14.79 $14.24 $14.65 1 099 938
Feb 09, 2024 $14.81 $15.00 $14.20 $14.42 1 178 234
Feb 08, 2024 $14.67 $15.08 $14.60 $14.70 505 661
Feb 07, 2024 $15.35 $15.43 $14.67 $14.71 585 892
Feb 06, 2024 $14.80 $15.49 $14.62 $15.40 1 843 318
Feb 05, 2024 $14.54 $14.61 $14.25 $14.55 562 695
Feb 02, 2024 $14.48 $14.76 $14.24 $14.69 571 773
Feb 01, 2024 $14.48 $14.76 $14.30 $14.72 701 681
Jan 31, 2024 $14.59 $14.96 $14.33 $14.39 829 894
Jan 30, 2024 $14.62 $14.74 $14.12 $14.62 1 030 931
Jan 29, 2024 $13.77 $14.79 $13.68 $14.60 1 500 785
Jan 26, 2024 $13.65 $14.00 $13.40 $13.83 1 182 594
Jan 25, 2024 $13.86 $13.87 $13.53 $13.72 935 279
Jan 24, 2024 $14.20 $14.43 $13.66 $13.70 1 159 973
Jan 23, 2024 $14.94 $15.06 $14.10 $14.17 1 373 403
Jan 22, 2024 $15.18 $15.19 $14.70 $14.90 1 145 827
Jan 19, 2024 $15.10 $15.10 $14.64 $14.98 1 149 952
Jan 18, 2024 $15.32 $15.44 $14.90 $15.04 678 656
Jan 17, 2024 $14.85 $15.45 $14.71 $15.39 2 193 750
Jan 16, 2024 $14.83 $15.01 $14.36 $14.88 908 557
Click to get the best stock tips daily for free!

About Avadel Pharmaceuticals plc

Avadel Pharmaceuticals plc Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorpo... AVDL Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT